Trypanosoma cruzi: acute infection affects expression of alpha-2-macroglobulin and A2MR/LRP receptor differently in C3H and C57BL/6 mice.
Although a complete cellular and humoral immune response is elicited in Chagas' disease, recent data suggest that other natural elements of innate immunity may also contribute to the initial host primary defense. alpha-Macroglobulins are a family of plasma proteinase inhibitors that are acute-phase reactants in Trypanosoma cruzi-infected mice and humans. Mice contain a tetrameric alpha-2-macroglobulin (MAM) and a monomeric murinoglobulin (MUG). Heterogeneity in their reactions was observed in murine T. cruzi-infected plasma A2M levels despite an overall increase. In addition, up-regulation of the A2M receptor (A2MR/LRP) was observed in peritoneal macrophages during T. cruzi infection. Here, we show that during T. cruzi infection (Y strain), the MAM and MUG hepatic mRNA levels and the corresponding plasma protein levels were up-regulated in C3H and C57BL/6 (B6) mice, but with different kinetics. On the contrary, A2MR/LRP mRNA levels increased in acutely infected C3H mice, but decreased in B6 mice, in both liver and heart. Immunocytochemistry of infected B6 heart cryosections confirmed a less intense endothelium labeling by the fluoresceinated ligand for A2MR/LRP. On the other hand, infected B6 spleen cells displayed higher F-A2M-FITC binding and MAC1 expression, confirming higher A2MR/LRP expression in macrophages. In uninfected mice, as well as after T. cruzi infection, higher A2M plasma levels were measured in C3H mice than in B6 mice. The lower tissue T. cruzi parasitism found in C3H-infected mice could reflect an inhibitory effect of A2M on parasite invasion. Our present data further contribute to clarifying aspects of the role of A2MR/LRP in a model of acute Chagas' disease in different mouse strains.
Soeiro
M de N
Mde N
Lab. Biologia Celular, DUBC, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil. soeiro@ioc.fiocruz.br
Paiva
M M
MM
Waghabi
M C
MC
Meirelles
M de N
Mde N
Lorent
K
K
Henriques-Pons
A
A
Coutinho
C M
CM
Van Leuven
F
F
Araújo-Jorge
T C
TC
D000208:Acute Disease; D000818:Animals; D014355:Chagas Disease / Q000235:genetics / Q000378:metabolism* / Q000469:parasitology; D015870:Gene Expression; D006321:Heart / Q000469:parasitology; D008099:Liver / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D009206:Myocardium / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D009929:Organ Size; D018512:Parasitemia / Q000235:genetics / Q000378:metabolism / Q000469:parasitology; D012333:RNA, Messenger / Q000032:analysis; D011971:Receptors, Immunologic / Q000096:biosynthesis* / Q000235:genetics; D012712:Serum Globulins / Q000096:biosynthesis / Q000235:genetics; D013154:Spleen / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D014349:Trypanosoma cruzi / Q000502:physiology; D015854:Up-Regulation; D000511:alpha-Macroglobulins / Q000096:biosynthesis* / Q000235:genetics
D026503:Low Density Lipoprotein Receptor-Related Protein-1; D012333:RNA, Messenger; D011971:Receptors, Immunologic; D012712:Serum Globulins; D000511:alpha-Macroglobulins; C044177:murinoglobulin